Complement Inhibition in the Treatment of SLE-Associated Thrombotic Thrombocytopenic Purpura
Main Authors: | Alexis Boneparth MD, L. Nandini Moorthy MD, MS, Lynne Weiss MD, Hariprem Rajasekhar MD, Susan Murphy MD, Richard A. Drachtman MD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2015-01-01
|
Series: | Global Pediatric Health |
Online Access: | https://doi.org/10.1177/2333794X15570150 |
Similar Items
-
Complement Regulatory Genetic Mutations in the Setting of Autoimmune Thrombotic Thrombocytopenic Purpura: A Case Series
by: Shebli Atrash, MD, et al.
Published: (2018-03-01) -
Educational Case: Differentiating Thrombotic Thrombocytopenic Purpura From Other Thrombotic Microangiopathies and Potential Role of the Spleen
by: Meredith M. Nichols MD, et al.
Published: (2021-03-01) -
Thrombotic Thrombocytopenic Purpura
by: Nuchanat Nonsee, et al.
Published: (2015-02-01) -
Atypical posterior reversible encephalopathy syndrome in a case of thrombotic thrombocytopenic purpura with Sjogren's syndrome
by: Rahul Hegde, MD FRCR, et al.
Published: (2021-06-01) -
Thrombotic Thrombocytopenic Purpura and Gemcitabine
by: Pashtoon Murtaza Kasi
Published: (2011-03-01)